AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22790176 — intervention group
Group type: EXPERIMENTAL
Intervention: VRET only
Number of subjects: 18
Study 22790176 — intervention group
Group type: COMPARATOR
Intervention: VRET with cognitive therapy
Number of subjects: 18
Study 20564068 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of oral modafinil daily
Number of subjects: 631
Study 20564068 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 631
Study 18086100 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate circumcision (intervention arm)
Number of subjects: 4456
Study 18086100 — intervention group
Group type: COMPARATOR
Intervention: Circumcision delayed for 24 months (control arm)
Number of subjects: 4456
Study 16301017 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological treatments (behavioural, cognitive-behavioural, cognitive)
Number of subjects: 0
Study 16301017 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological treatments
Number of subjects: 0
Study 16301017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural treatment
Number of subjects: 0
Study 16301017 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 14567294 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthwashing with tea tree oil
Number of subjects: 0
Study 14567294 — intervention group
Group type: COMPARATOR
Intervention: Xylitol
Number of subjects: 0
Study 11023927 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 460
Study 11023927 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin placebo
Number of subjects: 460
Study 11023927 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 460
Study 11023927 — intervention group
Group type: COMPARATOR
Intervention: Enalapril placebo
Number of subjects: 460
Study 10677983 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% end‐tidal sevoflurane concentration in 66% nitrous oxide (group I n = 25)
Number of subjects: 65
Study 10677983 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% end‐tidal sevoflurane concentration in 66% nitrous oxide (group II n = 20)
Number of subjects: 65
Study 10677983 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% end‐tidal sevoflurane concentration in 66% nitrous oxide (group III n = 20)
Number of subjects: 65
Study 10677983 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who moved at incision
Number of subjects: 65
Study 1586064 — intervention group
Group type: EXPERIMENTAL
Intervention: Small droplet aerosol (3.2 microns MMD)
Number of subjects: 9
Study 1586064 — intervention group
Group type: EXPERIMENTAL
Intervention: Large droplet aerosol (5.2 microns MMD)
Number of subjects: 9
Study 1586064 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin aerosols
Number of subjects: 9
Study 3923855 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) 20 mg inhaled four times a day for 2 months
Number of subjects: 56
Study 3923855 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen 1 mg orally twice a day for 2 months
Number of subjects: 56
Study 3923855 — intervention group
Group type: EXPERIMENTAL
Intervention: Clemastine 1 mg orally twice a day for 1 week
Number of subjects: 56
Study 3923855 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose) capsule twice a day for 2 months
Number of subjects: 56
Study 31469914 — intervention group
Group type: COMPARATOR
Intervention: Micro-needling (MN) alone in Group-A (9 patients)
Number of subjects: 41
Study 31469914 — intervention group
Group type: COMPARATOR
Intervention: 5-aminolevulinic acid photodynamic therapy (ALA-PDT) in Group-B (15 patients)
Number of subjects: 41
Study 31469914 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of micro-needling (MN) and 5-aminolevulinic acid photodynamic therapy (ALA-PDT) in Group-C (17 patients)
Number of subjects: 41
Study 29138293 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pathway implementation for suspected ACS including structured risk stratification, specified time points for ECG and troponin testing within 3 hours of arrival.
Number of subjects: 31332
Study 29138293 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pathway implementation for suspected ACS
Number of subjects: 31332
Study 25794468 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly bisphosphonate (minodronate)
Number of subjects: 147
Study 25794468 — intervention group
Group type: COMPARATOR
Intervention: Weekly bisphosphonate (alendronate or risedronate)
Number of subjects: 147
Study 23865463 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical supervision sessions facilitated by psychiatrists experienced in psycho-oncology.
Number of subjects: 0
Study 23865463 — intervention group
Group type: COMPARATOR
Intervention: Randomized control trial designed to reduce anxiety and depression of distressed adults with cancer.
Number of subjects: 0
Study 23096041 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptol, 25-35 mg/kg for 1-3 months
Number of subjects: 0
Study 20030661 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental hookworm infection (ten Necator americanus larvae)
Number of subjects: 32
Study 20030661 — intervention group
Group type: COMPARATOR
Intervention: Placebo (histamine solution)
Number of subjects: 32
Study 18534242 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP and hepatitis B vaccines
Number of subjects: 50
Study 18534242 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis B alone
Number of subjects: 50
Study 15933556 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamphlet and videotape promoting judicious use of antibiotics
Number of subjects: 499
Study 15933556 — intervention group
Group type: COMPARATOR
Intervention: Brochures about injury prevention (Control)
Number of subjects: 499
Study 12819508 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngo-fiberscope passed through the PEG feeding tube
Number of subjects: 12
Study 10228375 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream (1.5 g applied to three sites: back of the hand, antecubital fossa, side of the neck)
Number of subjects: 38
Study 10228375 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream (applied to contralateral sites)
Number of subjects: 38
Study 7699214 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide (LOP, 16 mg orally)
Number of subjects: 65
Study 7699214 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM, 1 mg orally overnight)
Number of subjects: 65
Study 2740833 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (5 mg Folacin) for 1 year
Number of subjects: 31
Study 4417678 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric patients who died
Number of subjects: 260
Study 30851062 — intervention group
Group type: EXPERIMENTAL
Intervention: evolocumab 140 mg every 2 weeks (Q2W)
Number of subjects: 453
Study 30851062 — intervention group
Group type: EXPERIMENTAL
Intervention: evolocumab 420 mg monthly (QM)
Number of subjects: 453
Study 30851062 — intervention group
Group type: EXPERIMENTAL
Intervention: evolocumab
Number of subjects: 453
Study 30851062 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 453
Study 27081164 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Greek dance rehabilitation programme (Group A)
Number of subjects: 40
Study 24782115 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra (interleukin-1 receptor antagonist)
Number of subjects: 80
Study 24782115 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 22085870 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education (twice weekly for 2 months)
Number of subjects: 184
Study 22085870 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nutrition education)
Number of subjects: 184
Study 19957031 — intervention group
Group type: EXPERIMENTAL
Intervention: lamivudine
Number of subjects: 80
Study 19957031 — intervention group
Group type: COMPARATOR
Intervention: control
Number of subjects: 80
Study 18164665 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative ECoG findings including focal spiking, focal slowing in theta or delta range, and ictaform ECoG patterns.
Number of subjects: 40
Study 18164665 — intervention group
Group type: EXPERIMENTAL
Intervention: Resected area including anterior mesial regions where interictal spikes, ictaform activity, and slowing were localized.
Number of subjects: 40
Study 15999135 — intervention group
Group type: EXPERIMENTAL
Intervention: FDT C-20-1 Screening Program
Number of subjects: 100
Study 15999135 — intervention group
Group type: COMPARATOR
Intervention: Humphrey Field Analyzer (HFA) SITA Fast algorithm and Program 24-2
Number of subjects: 100
Study 12957441 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 16 mg daily for two months
Number of subjects: 45
Study 10888955 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral pedicle screw fixation
Number of subjects: 87
Study 10888955 — intervention group
Group type: COMPARATOR
Intervention: Bilateral pedicle screw fixation
Number of subjects: 87
Study 9035511 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleus CMP forte (dysodic cytidinmonophosphate 5 mg, trisodic uridintriphosphate 3 mg, hydroxicobalamin 2 mg) tid for six months
Number of subjects: 46
Study 9035511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 9035511 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleus CMP forte
Number of subjects: 46
Study 1348775 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD)
Number of subjects: 331
Study 1348775 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SDD)
Number of subjects: 331
Study 3866536 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg slow-release pentoxifylline tablets ('Trental 400') twice a day for one week, followed by three times daily for seven weeks
Number of subjects: 38
Study 3866536 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 38
Study 30867201 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramide-dominant emollient applied two times per day from birth to 6 months
Number of subjects: 760
Study 30867201 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramide-dominant emollient
Number of subjects: 760
Study 29193350 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin nanomicelle 80 mg daily for 10 weeks
Number of subjects: 60
Study 29193350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 29193350 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin nanomicelle
Number of subjects: 60
Study 27508851 — intervention group
Group type: COMPARATOR
Intervention: Renal Denervation (RDN)
Number of subjects: 106
Study 27508851 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy with spironolactone (25 mg daily)
Number of subjects: 106
Study 27508851 — intervention group
Group type: COMPARATOR
Intervention: Complete RDN
Number of subjects: 106
Study 27508851 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone addition
Number of subjects: 106
Study 24906700 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (CRT) prior to surgery
Number of subjects: 410
Study 24906700 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 410
Study 24906700 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant CRT
Number of subjects: 410
Study 22364962 — intervention group
Group type: EXPERIMENTAL
Intervention: Group art therapy
Number of subjects: 417
Study 22364962 — intervention group
Group type: COMPARATOR
Intervention: Activity group
Number of subjects: 417
Study 22364962 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 417
Study 20677537 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning/morning regimen (5% BPO wash + Tretinoin gel microsphere 0.04% pump)
Number of subjects: 247
Study 20677537 — intervention group
Group type: COMPARATOR
Intervention: Morning/evening regimen (BPO in the morning/Tretinoin in the evening)
Number of subjects: 247
Study 20677537 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 247
Study 18271278 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc bis-glycinate (15 mg single dose)
Number of subjects: 12
Study 18271278 — intervention group
Group type: COMPARATOR
Intervention: Zinc gluconate (15 mg single dose)
Number of subjects: 12
Study 15673390 — intervention group
Group type: EXPERIMENTAL
Intervention: Inappropriate sinus tachycardia (IST) patients at rest
Number of subjects: 8
Study 15673390 — intervention group
Group type: EXPERIMENTAL
Intervention: Inappropriate sinus tachycardia (IST) patients during orthostatic stress
Number of subjects: 8
Study 15673390 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (Control group) at rest
Number of subjects: 8
Study 11895280 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined periodontal regenerative technique (CPRT) using anorganic bovine bone and a collagen membrane
Number of subjects: 34
Study 11895280 — intervention group
Group type: COMPARATOR
Intervention: GTR with a collagen membrane alone
Number of subjects: 34
Study 10549839 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate physical training programme for 6 months
Number of subjects: 20
Study 10549839 — intervention group
Group type: COMPARATOR
Intervention: Sedentary lifestyle (Control)
Number of subjects: 20
Study 8524727 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary and behavioral intervention
Number of subjects: 535
Study 1837120 — intervention group
Group type: EXPERIMENTAL
Intervention: LO‐Tact‐1 (10 mg i.v. per day) with cyclosporin (8 mg/kg/day), low‐dose steroids (1/2 mg/kg/day), and azathioprine (1 mg/kg/day starting at day 45)
Number of subjects: 15
Study 1837120 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporin, high‐dose steroids (2 mg/day at day 1), and a 14‐day course of polyclonal horse antilymphocyte globulins (ALG)
Number of subjects: 15
Study 1837120 — intervention group
Group type: EXPERIMENTAL
Intervention: LO‐Tact‐1 treatment
Number of subjects: 15
Study 1837120 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporin, high‐dose steroids, and ALG
Number of subjects: 15
Study 7073460 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip contractions at 15% of maximal voluntary contractions (% MVC)
Number of subjects: 7
Study 7073460 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip contractions at 25% of maximal voluntary contractions (% MVC)
Number of subjects: 7
Study 7073460 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip contractions at 35% of maximal voluntary contractions (% MVC)
Number of subjects: 7
Study 31287438 — intervention group
Group type: EXPERIMENTAL
Intervention: Large fascia graft (Group 1)
Number of subjects: 32
Study 31287438 — intervention group
Group type: COMPARATOR
Intervention: Small fascia graft (Group 2)
Number of subjects: 32
Study 31287438 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesteatoma pathology
Number of subjects: 32
Study 31287438 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulation tissue pathology
Number of subjects: 32
Study 31287438 — intervention group
Group type: EXPERIMENTAL
Intervention: Coexisting granulation with cholesteatoma pathology
Number of subjects: 32
Study 30033904 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronome assistance during CPR pre-arrival instructions
Number of subjects: 148
Study 30033904 — intervention group
Group type: COMPARATOR
Intervention: Standard pre-arrival instructions without metronome assistance
Number of subjects: 148
Study 27737408 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia group
Number of subjects: 160
Study 27737408 — intervention group
Group type: COMPARATOR
Intervention: Northermia group
Number of subjects: 160
Study 25301455 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone + Warfarin
Number of subjects: 2051
Study 25301455 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone + Apixaban
Number of subjects: 2051
Study 25301455 — intervention group
Group type: COMPARATOR
Intervention: No Amiodarone + Warfarin
Number of subjects: 2051
Study 25301455 — intervention group
Group type: COMPARATOR
Intervention: No Amiodarone + Apixaban
Number of subjects: 2051
Study 22708952 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy for 8 months
Number of subjects: 164
Study 20165861 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative and postoperative autotransfusion (Group 1, n:92)
Number of subjects: 248
Study 20165861 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative autotransfusion (Group 2, n:71)
Number of subjects: 248
Study 20165861 — intervention group
Group type: COMPARATOR
Intervention: Allogeneic blood transfusion only (Control Group 0, n:85)
Number of subjects: 248
Study 17540994 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine injected into the endothoracic tissue around the internal thoracic artery before dissection
Number of subjects: 75
Study 17540994 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine injected into the periarterial tissues of the internal thoracic artery pedicle
Number of subjects: 75
Study 17540994 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraluminal papaverine applied retrogradely into the internal thoracic artery
Number of subjects: 75
Study 16269591 — intervention group
Group type: EXPERIMENTAL
Intervention: OSEM with depth-dependant resolution recovery and temporal Fourier filtering
Number of subjects: 40
Study 16269591 — intervention group
Group type: COMPARATOR
Intervention: Filtered backprojection (FBP)
Number of subjects: 40
Study 12010933 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular pacing
Number of subjects: 13
Study 12010933 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacing
Number of subjects: 13
Study 12010933 — intervention group
Group type: COMPARATOR
Intervention: Baseline (right ventricular pacing)
Number of subjects: 13
Study 10541316 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant Epo (rEpo) treatment
Number of subjects: 122
Study 10541316 — intervention group
Group type: COMPARATOR
Intervention: Asphyxia
Number of subjects: 122
Study 10541316 — intervention group
Group type: COMPARATOR
Intervention: Intraventricular hemorrhage (IVH)
Number of subjects: 122
Study 10541316 — intervention group
Group type: COMPARATOR
Intervention: Meningitis
Number of subjects: 122
Study 10541316 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 122
Study 7477086 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii (SB) 750 mg daily (250 mg t.i.d.) for 21 days
Number of subjects: 0
Study 7477086 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii (SB)
Number of subjects: 0
Study 2182329 — intervention group
Group type: EXPERIMENTAL
Intervention: Q fever vaccine
Number of subjects: 200
Study 2182329 — intervention group
Group type: COMPARATOR
Intervention: Influenza vaccine
Number of subjects: 200
Study 82030 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous levamisole treatment
Number of subjects: 363
Study 82030 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent levamisole treatment
Number of subjects: 363
Study 82030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 363
Study 82030 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole (both regimens)
Number of subjects: 363
Study 31160080 — intervention group
Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene strips as an adjunct to epinephrine‐impregnated gauze (test group, n = 15)
Number of subjects: 30
Study 31160080 — intervention group
Group type: COMPARATOR
Intervention: Aluminum chloride (control, n = 15)
Number of subjects: 30
Study 28452620 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive periodontal therapy for 4 weeks
Number of subjects: 95
Study 28452620 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (CT)
Number of subjects: 95
Study 25559202 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic risk selection with the Rotterdam Reproductive Risk Reduction (R4U) score card and referral to care pathways
Number of subjects: 3500
Study 25559202 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard antenatal care)
Number of subjects: 3500
Study 23594451 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (3 sessions per week, 60 minutes each for 6 weeks)
Number of subjects: 135
Study 23594451 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 135
Study 22085402 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mol/L hydrochloric acid infusion
Number of subjects: 55
Study 22085402 — intervention group
Group type: COMPARATOR
Intervention: Water infusion
Number of subjects: 55
Study 19308439 — intervention group
Group type: EXPERIMENTAL
Intervention: Radon baths (80 Bq/l) for 15 days
Number of subjects: 27
Study 19308439 — intervention group
Group type: COMPARATOR
Intervention: Thermal water with negligible radon content (6 Bq/l) for 15 days
Number of subjects: 27
Study 17308218 — intervention group
Group type: EXPERIMENTAL
Intervention: Elemental diet
Number of subjects: 30
Study 17308218 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone 15 mg/day
Number of subjects: 30
Study 15347564 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic oxygen control
Number of subjects: 12
Study 15347564 — intervention group
Group type: COMPARATOR
Intervention: Routine manual oxygen control
Number of subjects: 12
Study 15347564 — intervention group
Group type: COMPARATOR
Intervention: Optimal control by a fully dedicated person
Number of subjects: 12
Study 11577835 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg alteplase (15 mg as bolus, followed by an infusion of 35 mg over 60 min) plus tirofiban (0.4 mcg/kg/min for 30 min followed by an infusion of 0.1 mcg/kg/min for 3 days)
Number of subjects: 120
Study 10021959 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5%
Number of subjects: 40
Study 10021959 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.5%
Number of subjects: 40
Study 10021959 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 7931525 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile stimulation using a series of pulses applied to adjacent locations on the skin with varying spatiotemporal parameters.
Number of subjects: 0
Study 7931525 — intervention group
Group type: COMPARATOR
Intervention: Stimulation of only two points on the skin (start and stop locations).
Number of subjects: 0